Terms: = Endocrine gland cancer AND PIM1, PIM, 5292, ENSG00000137193, P11309
52 results:
1. Combined BRAF and pim1 inhibitory therapy for papillary thyroid carcinoma based on BRAFV600E regulation of pim1: Synergistic effect and metabolic mechanisms.
Xu Q; Wang J; Mao Y; Xuan Z; Yang K; Tang X; Zhu X
Neoplasia; 2024 Jun; 52():100996. PubMed ID: 38593698
[TBL] [Abstract] [Full Text] [Related]
2. AUM302, a novel triple kinase pim/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor.
Ingle K; LaComb JF; Graves LM; Baines AT; Bialkowska AB
PLoS One; 2023; 18(11):e0294065. PubMed ID: 37943821
[TBL] [Abstract] [Full Text] [Related]
3. Subcellular localization of nucleolar protein 14 and its proliferative function mediated by miR-17-5p and E2F4 in pancreatic cancer.
Du YX; Zhou Y; Zheng XH; Duan YJ; Gu ZT; Yin YF; Wang CF
Aging (Albany NY); 2023 Jul; 15(14):7308-7323. PubMed ID: 37506248
[TBL] [Abstract] [Full Text] [Related]
4. [Clinicopathologic characteristics and prognostic analysis of testicular diffuse large B-cell lymphoma].
Wang Y; Shi ZY; Shi Q; Wang S; Zhang MC; Shen R; He Y; Qiu HL; Yi HM; Dong L; Wang L; Cheng S; Xu PP; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):321-327. PubMed ID: 37357002
[No Abstract] [Full Text] [Related]
5. Endoscopic versus Nonendoscopic Surgery for Resection of Craniopharyngiomas.
Abiri A; Roman KM; Latif K; Goshtasbi K; Torabi SJ; Lehrich BM; Mohyeldin A; Hsu FPK; Kuan EC
World Neurosurg; 2022 Nov; 167():e629-e638. PubMed ID: 36041722
[TBL] [Abstract] [Full Text] [Related]
6. LncRNA RGMB-AS1 facilitates pancreatic cancer cell proliferation and migration but inhibits cell apoptosis via miR-574-3p/pim3 axis.
Song W; Shi C
Am J Physiol Gastrointest Liver Physiol; 2021 Nov; 321(5):G477-G488. PubMed ID: 34468207
[TBL] [Abstract] [Full Text] [Related]
7. Role of oncogene pim-1 in the development and progression of papillary thyroid carcinoma: Involvement of oxidative stress.
Wen QL; Yi HQ; Yang K; Yin CT; Yin WJ; Xiang FY; Bao M; Shuai J; Song YW; Ge MH; Zhu X
Mol Cell Endocrinol; 2021 Mar; 523():111144. PubMed ID: 33383107
[TBL] [Abstract] [Full Text] [Related]
8. Determining the Relative Gene Expression Level of Hypoxia Related Genes in Different cancer Cell Lines.
Baqlouq L; Zihlif M; Hammad H; Thaib TMA
Curr Mol Pharmacol; 2021; 14(1):52-59. PubMed ID: 32436837
[TBL] [Abstract] [Full Text] [Related]
9. DNA Methylation-Derived Immune Cell Profiles, CpG Markers of Inflammation, and Pancreatic cancer Risk.
Michaud DS; Ruan M; Koestler DC; Alonso L; Molina-Montes E; Pei D; Marsit CJ; De Vivo I; Malats N; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1577-1585. PubMed ID: 32430337
[TBL] [Abstract] [Full Text] [Related]
10. Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating pim1.
Li Q; Jiang C; Wang Y; Wei M; Zheng H; Xu Y; Xu X; Jia F; Liu K; Sun G; Zang J; Mo P
Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1477-1489. PubMed ID: 31292669
[TBL] [Abstract] [Full Text] [Related]
11. JAK/STAT3 and NF-κB Signaling Pathways Regulate cancer Stem-Cell Properties in Anaplastic Thyroid cancer Cells.
Shiraiwa K; Matsuse M; Nakazawa Y; Ogi T; Suzuki K; Saenko V; Xu S; Umezawa K; Yamashita S; Tsukamoto K; Mitsutake N
Thyroid; 2019 May; 29(5):674-682. PubMed ID: 30784360
[No Abstract] [Full Text] [Related]
12. Comparison of Monitor-Image and Printout-Image Methods in Ki-67 Scoring of Gastroenteropancreatic Neuroendocrine Tumors.
Dogukan FM; Yilmaz Ozguven B; Dogukan R; Kabukcuoglu F
Endocr Pathol; 2019 Mar; 30(1):17-23. PubMed ID: 30367334
[TBL] [Abstract] [Full Text] [Related]
13. DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts.
Wegner CS; Hauge A; Simonsen TG; Gaustad JV; Andersen LMK; Rofstad EK
Neoplasia; 2018 Jul; 20(7):734-744. PubMed ID: 29886124
[TBL] [Abstract] [Full Text] [Related]
14. pim Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian cancer.
Aziz AUR; Farid S; Qin K; Wang H; Liu B
Biomolecules; 2018 Feb; 8(1):. PubMed ID: 29401696
[TBL] [Abstract] [Full Text] [Related]
15. MiR-377 inhibits the proliferation of pancreatic cancer by targeting pim-3.
Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
[TBL] [Abstract] [Full Text] [Related]
16. pim-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value.
Xu J; Xiong G; Cao Z; Huang H; Wang T; You L; Zhou L; Zheng L; Hu Y; Zhang T; Zhao Y
J Exp Clin Cancer Res; 2016 Sep; 35(1):133. PubMed ID: 27596051
[TBL] [Abstract] [Full Text] [Related]
17. Guanylate-Binding Protein-1 protects ovarian cancer cell lines but not breast cancer cell lines from killing by paclitaxel.
Tipton AR; Nyabuto GO; Trendel JA; Mazur TM; Wilson JP; Wadi S; Justinger JS; Moore GL; Nguyen PT; Vestal DJ
Biochem Biophys Res Commun; 2016 Sep; 478(4):1617-23. PubMed ID: 27590579
[TBL] [Abstract] [Full Text] [Related]
18. pim-3 contributes to radioresistance through regulation of the cell cycle and DNA damage repair in pancreatic cancer cells.
Chen XY; Wang Z; Li B; Zhang YJ; Li YY
Biochem Biophys Res Commun; 2016 Apr; 473(1):296-302. PubMed ID: 27016481
[TBL] [Abstract] [Full Text] [Related]
19. Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer.
Wei ZR; Liang C; Feng D; Cheng YJ; Wang WM; Yang DJ; Wang YX; Cai QP
Oncotarget; 2016 Apr; 7(14):17737-50. PubMed ID: 26894969
[TBL] [Abstract] [Full Text] [Related]
20. Design and synthesis of an in vivo-efficacious pim3 kinase inhibitor as a candidate anti-pancreatic cancer agent.
Nakano H; Hasegawa T; Saito N; Furukawa K; Mukaida N; Kojima H; Okabe T; Nagano T
Bioorg Med Chem Lett; 2015 Dec; 25(24):5687-93. PubMed ID: 26547690
[TBL] [Abstract] [Full Text] [Related]
[Next]
